Genentech says FDA approves Actemra arthritis drug - Worcester Telegram & Gazette
The approval of the drug, Actemra, “marks a major step forward” in the treatment of the disease, Hal Barron, chief medical officer for Genentech and its parent company, the Roche Group, said in a statement. Development of the drug involved five Phase …
Source: www.telegram.com